OK...So not everything is in the article,but it spells out the latest deal with Cannvalate and possible financial contribution from the Deal (with Options) and up To 50% R&D refund for that deal.
Since last 4C add $735,000 from final tranche of Cap Raise (Jan 1st)....and previously March and June Qtrs added revenues of $438,000 and $391,000.....Could be Up to $300,000 for previous R&D also.
That's rough,but I think fairly accurate....I stand to be corrected.
OK...So not everything is in the article,but it spells out the...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
